When to Start, What to Start and Other Treatment Controversies in Pediatric HIV Infection

Author： Turkova Anna   Webb Rachel H.   Lyall Hermione  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.14, Iss.6, 2012-12, pp. : 361-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

When to stART for HIV? SMART answer: immediately

By  

Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Recombinant Erythropoietin for Anaemia of Prematurity—When Should Treatment Start?

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 37, Iss. 3, 2007-09 ,pp. : 217-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phosphate binders in chronic kidney disease. When should we start, what should we prescribe?

By Malindretos Pavlos  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2255-2256

Informa Healthcare

Access to resources Recommend Favorite

When to start antiretroviral therapy: asking the right question

By Powderly William G  

Future Virology, Vol. 6, Iss. 4, 2011-04 ,pp. : 401-403

Future Medicine

Access to resources Recommend Favorite

Darunavir: In Treatment-Experienced Pediatric Patients with HIV-1 Infection

By McKeage Kate   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 123-131

Adis International

Access to resources Recommend Favorite